Evidence map›Paper›PMID 21774491›Full record

ReviewBiochemistry2011

Cytoplasmic permeation pathway of neurotransmitter transporters.

Gary Rudnick

Abstract readReview
In one paragraph

Review in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Two Lignan Glycosides fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Chloride-dependent conformational changes in the GlyT1 glycine transporter.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Conformational cycle and ion-coupling mechanism of the Na+/hydantoin transporter Mhp1.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  19. The Concise Guide to PHARMACOLOGY 2013/14: transporters.British journal of pharmacology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gary RudnickDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520-8066, United States. gary.rudnick@yale.edu
Yale University · US

Funding

STRUCTURE/FUNCTION OF THE HUMAN DOPAMINE TRANSPORTERP01DA012408 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI WEINSTEIN, HAREL · 1999 to 2015
$14.2M
ION AND BIOGENIC AMINE TRANSPORT MECHANISMSR01DA007259 · NIDA · YALE UNIVERSITY · PI RUDNICK, GARY W · 1992 to 2016
$4.7M
NEUROTRANSMITTER TRANSPORTR01DA008213 · NIDA · YALE UNIVERSITY · PI RUDNICK, GARY W · 1993 to 2014
$3.5M
NIDA NIH HHS DA007259NIDA NIH HHS DA008213NIDA NIH HHS DA012408NIDA NIH HHS P01 DA012408NIDA NIH HHS R01 DA007259NIDA NIH HHS R01 DA008213
6 · The paper itself

Abstract

Ion-coupled solute transporters are responsible for transporting nutrients, ions, and signaling molecules across a variety of biological membranes. Recent high-resolution crystal structures of several transporters from protein families that were previously thought to be unrelated show common structural features indicating a large structural family representing transporters from all kingdoms of life. This review describes studies that led to an understanding of the conformational changes required for solute transport in this family. The first structure in this family showed the bacterial amino acid transporter LeuT, which is homologous to neurotransmitter transporters, in an extracellularly oriented conformation with a molecule of leucine occluded at the substrate site. Studies with the mammalian serotonin transporter identified positions, buried in the LeuT structure, that defined a potential pathway leading from the cytoplasm to the substrate binding site. Modeling studies utilized an inverted structural repeat within the LeuT crystal structure to predict the conformation of LeuT in which the cytoplasmic permeation pathway, consisting of positions identified in SERT, was open for diffusion of the substrate to the cytoplasm. From the difference between the model and the crystal structures, a simple "rocking bundle" mechanism was proposed, in which a four-helix bundle changed its orientation with respect to the rest of the protein to close the extracellular pathway and open the cytoplasmic one. Subsequent crystal structures from structurally related proteins provide evidence supporting this model for transport.

Indexed as

Amino Acid SequenceAnimalsCell Membrane PermeabilityCytoplasmHumansLeucineMolecular Sequence DataNeurotransmitter Transport ProteinsProtein ConformationSignal TransductionLeucineNeurotransmitter Transport Proteins

Identifiers

PMID21774491
PMCPMC3164596
OpenAlexW2033732946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.